- May 12, 2010
Annual Meeting of Shareholders - BELLUS Health provides update on corporate and product developments
LAVAL, QC, May 12 /CNW Telbec/ - BELLUS Health Inc. (TSX: BLU) ("BELLUS Health" or the "Company") held its Annual and Special Meeting of Shareholders today. President and Chief Executive Officer Roberto Bellini provided ...
BELLUS Health reports results for first quarter ended March 31, 2010
LAVAL, QC, May 12 /CNW Telbec/ - BELLUS Health Inc. (TSX: BLU) ("BELLUS Health" or the "Company") reported today its financial results for the first quarter ended March 31, 2010. ...
/R E P E A T -- BELLUS Health Inc. Annual and Special Meeting of Shareholders May 12, 2010/
LAVAL, QC, May 11 /CNW Telbec/ - Dr. Francesco Bellini, Chairman of BELLUS Health Inc. (TSX: BLU), invites all shareholders to attend the Annual and Special Meeting of Shareholders to be held on Wednesday, May 12, 2010 at ...
- May 11, 2010
BELLUS Health Inc. Annual and Special Meeting of Shareholders May 12, 2010
LAVAL, QC, May 11 /CNW Telbec/ - Dr. Francesco Bellini, Chairman of BELLUS Health Inc. (TSX: BLU), invites all shareholders to attend the Annual and Special Meeting of Shareholders to be held on Wednesday, May 12, 2010 at ...
- May 4, 2010
BELLUS Health ends NC-503 diabetes development program following results
LAVAL, QC, May 4 /CNW Telbec/ - BELLUS Health (TSX: BLU) announced today that it will discontinue its NC-503 diabetes development program following the results of the recently completed Phase IIa clinical proof-of-concept ...
- April 29, 2010
BELLUS Health and Celtic Therapeutics enter agreement for BELLUS' drug candidate KIACTA(TM)
KIACTA(TM) advancing to a confirmatory Phase III clinical trial LAVAL, QC, April 29 /CNW Telbec/ - BELLUS Health (TSX: BLU) and Celtic Therapeutics announced today that they have signed a final agreement pursuant ...
- April 1, 2010
LAVAL, QC, April 1 /CNW Telbec/ - BELLUS Health Inc. (TSX: BLU) ("BELLUS Health" or the "Company") announced today that, on March 30, 2010, the Company initiated a Phase I clinical study for NRM8499, a prodrug of ...
- February 24, 2010
BELLUS Health reports results for fourth quarter and year ended December 31, 2009
LAVAL, QC, Feb. 24 /CNW Telbec/ - BELLUS Health Inc. (TSX: BLU) (the "Company") reported today its financial results for the fourth quarter and year ended December 31, 2009. All currency figures reported in this press ...
- December 15, 2009
MONTREAL, Dec. 15 /CNW Telbec/ - The Board of Directors of BELLUS Health Inc. (the "Company") (TSX: BLU) is pleased to announce that Mr. Roberto Bellini has been named President and Chief Executive Officer of BELLUS ...
- November 10, 2009
BELLUS Health reports results for third quarter of fiscal 2009
LAVAL, QC, Nov. 10 /CNW Telbec/ - BELLUS Health Inc. (TSX: BLU) (the Company) reports financial results for the third quarter and nine-months ended September 30, 2009. The Company reported a reduced net loss, compared ...
- September 8, 2009
BELLUS Health announces results of rights offering
Company to present at the Rodman and Renshaw 11th Annual Healthcare Conference ...
- August 11, 2009
BELLUS Health reports results for first half of fiscal 2009
LAVAL, QC, Aug. 11 /CNW Telbec/ - BELLUS Health Inc. ("BELLUS Health" or the "Company") (TSX: BLU) reported results for the second quarter and first ...
- July 16, 2009
ECUBLENS, SWITZERLAND, July 16 /CNW Telbec/ - BELLUS Health (International) Limited, a wholly owned subsidiary of BELLUS Health Inc. ...
- July 15, 2009
BELLUS Health Inc. Announces Record Date for $12 Million Rights Offering To Common Shareholders
LAVAL, QC, July 15 /CNW Telbec/ - BELLUS Health Inc. (TSX: BLU) today announced that it has set August 5, 2009, as the record date for its ...
- July 7, 2009
BELLUS Health Inc. Announces $12 Million Rights Offering To Common Shareholders
Signs Standby Purchase Agreement for $8 million Company Announces VP, Finance ...
- July 6, 2009
Tramiprosate North American Phase III Clinical Study Results Published in Journal of Nutrition, Health and Aging ...
- June 5, 2009
BELLUS Health Inc. Announces Officer
LAVAL, QC, June 5 /CNW Telbec/ - BELLUS Health Inc. (TSX:BLU) announces that, following its Annual General Meeting held yesterday, the Board of ...
- June 4, 2009
LAVAL, QC, June 4 /CNW Telbec/ - BELLUS Health Inc. (TSX: BLU) (BELLUS Health or the Company) held its Annual General Meeting of Shareholders today, ...
- June 2, 2009
BELLUS Health Inc. Annual General Meeting of Shareholders June 4, 2009
LAVAL, QC, June 2 /CNW Telbec/ - Dr. Francesco Bellini, Chairman, President and Chief Executive Officer of BELLUS Health Inc. (TSX: BLU), ...
- May 6, 2009
BELLUS Health reports results for first quarter of fiscal 2009
LAVAL, QC, May 6 /CNW Telbec/ - BELLUS Health Inc. ("BELLUS Health" or the "Company") (TSX: BLU) reported results for the first quarter ended March ...
- April 24, 2009
BELLUS announces Chief Financial Officer to depart effective May 22, 2009
LAVAL, QC, April 24 /CNW Telbec/ - BELLUS Health announced today that Vice President, Finance and Chief Financial Officer Mr. Mariano Rodriguez will ...
- April 16, 2009
BELLUS Health inc. announces completion of first tranche of financing
LAVAL, QC, April 16 /CNW Telbec/ - Further to the press releases of March 31 and April 8, 2009, BELLUS Health Inc. ("BELLUS Health") (TSX: BLU) is ...
- April 8, 2009
BELLUS Health Inc. provides an update on the financing and the restructuring of existing notes
LAVAL, QC, April 8 /CNW Telbec/ - Further to the press release of March 31, 2009, BELLUS Health Inc. ("BELLUS Health") (TSX: BLU) is providing ...
- March 31, 2009
BELLUS Health Inc. provides financing update and announces restructuring of existing notes
LAVAL, QC, March 31 /CNW Telbec/ - BELLUS Health Inc. (the "Company") (TSX: BLU) announced today that it has entered into binding letter agreements ...
- March 24, 2009
BELLUS Health provides financing update
LAVAL, QC, March 24 /CNW Telbec/ - Further to the press release issued on February 26, 2009, BELLUS Health Inc. (TSX: BLU) reports that, notwithstanding ...
- March 12, 2009
BELLUS Health announces staff reductions to lower operating expenses
LAVAL, QC, March 12 /CNW Telbec/ - BELLUS Health Inc. (TSX: BLU) announced today that it has reduced its workforce by approximately 45%, ...
- February 26, 2009
BELLUS Health reports results for the fourth quarter of 2008
LAVAL, QC, Feb. 26 /CNW Telbec/ - BELLUS Health Inc. (TSX: BLU) reported today its results for the fourth quarter ended December 31, 2008, and ...
- December 17, 2008
BELLUS Health announces formal notice to voluntarily delist from NASDAQ
BELLUS Health Successfully Completed and Closed the Amendment of the -------------------------------------------------------------------- ...
- December 5, 2008
BELLUS Health is Preparing to Voluntarily Delist from the NASDAQ Capital Market
BELLUS Health Receives NASDAQ Deficiency Notice Relating to Market Value ------------------------------------------------------------------------ ...
- November 13, 2008
BELLUS Health Announces Stock Listing Transfer from NASDAQ Global Market to NASDAQ Capital Market
LAVAL, QC, Nov. 13 /CNW Telbec/ - BELLUS Health Inc. (NASDAQ: BLUS; TSX: BLU) announces today that it has received approval from the NASDAQ Listing ...
- November 10, 2008
BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update
LAVAL, QC, Nov. 10 /CNW Telbec/ - BELLUS Health Inc. (NASDAQ: BLUS; TSX: BLU) reports results for the third quarter ended September 30, 2008. For the ...
- November 6, 2008
BELLUS Health to present at the Rodman and Renshaw 10th Annual Healthcare Conference
Presentation will be Web cast live ...
- October 21, 2008
BELLUS Health provides update on activities
LAVAL, QC, Oct. 21 /CNW Telbec/ - BELLUS Health Inc. (NASDAQ: BLUS; TSX: BLU) is pleased to provide an update on its branded nutraceutical and ...
- October 15, 2008
BELLUS Health Receives Nasdaq Deficiency Notice Relating to Market Value
LAVAL, QC, Oct. 15 /CNW Telbec/ - BELLUS Health Inc. (NASDAQ: BLUS; TSX: BLU) announces that it received a Nasdaq Staff Deficiency Letter dated ...
- September 2, 2008
A new generation of memory protection ...
- August 12, 2008
Correction from source - BELLUS Health
LAVAL, QC, Aug. 12 /CNW Telbec/ - A correction from source is issued with respect to the BELLUS Health Inc. (NASDAQ: BLUS; TSX: BLU) release issued on ...
- August 5, 2008
LAVAL, QC, Aug. 5 /CNW Telbec/ - BELLUS Health Inc. (NASDAQ: BLUS; TSX: BLU) announced meaningful progress in both its nutraceutical and ...
- July 17, 2008
BELLUS Health announces closing of Innodia acquisition
Company announces change to senior management team -------------------------------------------------- ...
- July 16, 2008
BELLUS Health signs agreement to acquire Innodia
LAVAL, QC, July 16 /CNW Telbec/ - BELLUS Health Inc. (NASDAQ: BLUS; TSX: BLU, formerly known as Neurochem Inc.) announced today that it has signed a ...
- May 15, 2008
BELLUS Health to present at the Rodman and Renshaw 5th Annual Global Healthcare Conference
Presentation will be Web cast live ...
- May 5, 2008
BELLUS HEALTH reports results for first quarter of fiscal 2008
LAVAL, QC, May 5 /CNW Telbec/ - BELLUS Health Inc. (NASDAQ: BLUS; TSX: BLU, formerly known as Neurochem Inc.) reported results for the first quarter ...
- April 15, 2008
Neurochem Annual and Special Meeting web cast live ...
LAVAL, QC, April 11 /CNW Telbec/ - Dr. Francesco Bellini, Chairman, President and Chief Executive Officer of Neurochem Inc., invites the news ...
- April 11, 2008
Media advisory - Neurochem's Annual and Special Meeting of Shareholders April 15, 2008
LAVAL, QC, April 11 /CNW Telbec/ - Dr. Francesco Bellini, Chairman, President and Chief Executive Officer of Neurochem Inc., invites the news ...
Neurochem Annual and Special Meeting of shareholders
Neurochem will host a live Web conference on Tuesday, April 15, 2008, at ------------------------------------------------------------------------ ...
- March 13, 2008
Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosis
ECUBLENS, SWITZERLAND, March 13 /CNW Telbec/ - Neurochem (International) Limited (Neurochem), a wholly-owned subsidiary of Neurochem Inc. (NASDAQ: ...
- February 21, 2008
Neurochem announces departure of two members of management team
LAVAL, QC, Feb. 21 /CNW Telbec/ - In light of Neurochem Inc.'s (NASDAQ: NRMX; TSX: NRM) new strategic direction, the Company announces the ...
- February 20, 2008
Neurochem will host a conference call Thursday, February 21, 2008, at 8:30 A.M. ET. ...
- February 11, 2008
Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast live
LAVAL, QC, Feb. 11 /CNW Telbec/ - Neurochem Inc. (NASDAQ: NRMX; TSX: NRM) announces today that on Wednesday, February 13, 2008, Dr. Francesco Bellini, ...
- January 30, 2008
Neurochem appoints Mr. Gary Schmid as CEO of new nutraceutical business
LAVAL, QC, Jan. 30 /CNW Telbec/ - Neurochem Inc. (NASDAQ: NRMX; TSX: NRM) is pleased to announce that Mr. Gary Schmid will join Neurochem, effective ...
- January 3, 2008
Neurochem to present at JPMorgan Healthcare Conference
LAVAL, QC, Jan. 3 /CNW Telbec/ - Neurochem Inc. (NASDAQ: NRMX; TSX: NRM) announces today that on Thursday, January 10, 2008, Dr. Francesco Bellini, ...
- December 14, 2007
Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis
ECUBLENS, Switzerland, Dec. 14 /CNW Telbec/ - Neurochem (International) Limited (Neurochem), a wholly-owned subsidiary of Neurochem Inc. (NASDAQ: ...
- December 6, 2007
ECUBLENS, Switzerland, Dec. 6 /CNW Telbec/ - Neurochem (International) Limited (Neurochem), a wholly-owned subsidiary of Neurochem Inc. (NASDAQ: ...
- November 30, 2007
Neurochem announces departure of Dr. Philippe Calais, President, Global Business
LAVAL, QC, Nov. 30 /CNW Telbec/ - Neurochem Inc. (NASDAQ: NRMX; TSX: NRM) today announces the departure of Philippe Calais, PhD. Pharm., Neurochem's ...
- November 8, 2007
Neurochem announces important initiatives to provide medical and health benefits to patients
Neurochem will host a live web conference today November 8, 2007, at 8:30 AM ET ...
- November 7, 2007
Neurochem reports results for third quarter of fiscal 2007
Neurochem will host a live web conference Thursday November 8, 2007, at 8:30 AM ET. ...
- August 28, 2007
Neurochem provides information on cash position
LAVAL, QC, Aug. 28 /CNW Telbec/ - Following the issuance of a press release on August 26, 2007, announcing results from the tramiprosate ...
- August 26, 2007
Neurochem Announces results from Tramiprosate (ALZHEMED(TM)) North American Phase III Clinical Trial
Neurochem will host a conference call tomorrow August 27, 2007, at 8:30 AM EDT. ...
- August 9, 2007
Neurochem reports results for second quarter of fiscal 2007
Neurochem will host a conference call, August 9, 2007, at 5:00 PM EDT. ...
- July 24, 2007
Neurochem granted Fast Track designation from U.S. FDA for tramiprosate (ALZHEMED(TM))
Neurochem to meet with FDA to discuss statistical models for the completed North American Phase III clinical trial ...
- July 17, 2007
Neurochem receives approvable letter for eprodisate (KIACTA(TM)) for treatment of AA amyloidosis
ECUBLENS, Switzerland, July 17 /CNW Telbec/ - Neurochem (International) Limited (Neurochem), a wholly-owned subsidiary of Neurochem Inc. (NASDAQ: ...
- June 26, 2007
Neurochem to present at Jefferies Healthcare Conference
LAVAL, QC, June 26 /CNW Telbec/ - Neurochem Inc. (NASDAQ: NRMX; TSX: NRM) announces today that on Wednesday, June 27, 2007, Dr. Francesco Bellini, ...
- June 22, 2007
Tramiprosate (ALZHEMED(TM)) North American Phase III clinical trial progress update
LAVAL, QC, June 22 /CNW Telbec/ - Neurochem Inc. (NASDAQ: NRMX; TSX: NRM) has issued an update on the progress made since announcing in April 2007 that ...
- June 21, 2007
LAVAL, QC, June 21 /CNW Telbec/ - Neurochem Inc. (NASDAQ: NRMX; TSX: NRM) announces that it has received a third recommendation from the European Data ...
- June 18, 2007
LAVAL, QC, June 18 /CNW Telbec/ - Neurochem Inc. (NASDAQ: NRMX, TSX: NRM) announced today that it has given notice of mandatory conversion into common ...
- June 11, 2007
WASHINGTON, DC, June 11 /CNW Telbec/ - Paul S. Aisen, M.D., Professor of Neurology and Medicine at Georgetown University Medical Center, and principal ...
- June 7, 2007
ECUBLENS, SWITZERLAND, June 7 /CNW Telbec/ - Neurochem (International) Limited (Neurochem), a wholly-owned subsidiary of Neurochem Inc. (NASDAQ: ...
- June 5, 2007
LAVAL, QC, June 5 /CNW Telbec/ - Neurochem Inc. ("Neurochem") (NASDAQ: NRMX, TSX: NRM) announced today that, in connection with its previously ...
- May 8, 2007
The Neurochem AGM will be web cast live ...
Neurochem reports results for first quarter of fiscal 2007
LAVAL, QC, May 8 /CNW Telbec/ - Neurochem Inc. (NASDAQ: NRMX; TSX: NRM) reported results for the first quarter ended March 31, 2007. The Company ...
- May 7, 2007
Media advisory - Neurochem's Annual General Meeting of Shareholders on May 8, 2007
MONTREAL, May 7 /CNW Telbec/ - Dr. Francesco Bellini, Chairman, President and Chief Executive Officer of Neurochem Inc., invites the news media to the ...
- May 2, 2007
LAVAL, QC, May 2 /CNW Telbec/ - Neurochem Inc. (NASDAQ: NRMX, TSX: NRM) announced today a private placement of US$80 million aggregate principal ...
- April 19, 2007
LAVAL, QC, April 19 /CNW Telbec/ - Neurochem Inc. (NASDAQ: NRMX; TSX: NRM) announces that the database for the North American Phase III clinical ...
- April 11, 2007
Neurochem's eprodisate (KIACTA(TM)) PDUFA date extended three months by FDA
ECUBLENS, Switzerland, April 11 /CNW Telbec/ - Neurochem (International) Limited (Neurochem), a wholly owned subsidiary of Neurochem Inc. ...
- February 21, 2007
Neurochem reports results for fourth quarter and fiscal year 2006
Neurochem will host a conference call Thursday, February 22, 2007, at 8:30 A.M. ET. ...
- February 13, 2007
LAVAL, QC, Feb. 13 /CNW Telbec/ - Neurochem Inc. (NASDAQ: NRMX; TSX: NRM) announces that it has received a second recommendation from the European Data ...
- February 1, 2007
LAVAL, QC, Feb. 1 /CNW Telbec/ - Neurochem Inc. (NASDAQ: NRMX, TSX: NRM) announces the completion of its 18-month North American Phase III clinical ...